Largest health care biotech companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Amgen leads the 21 health care biotech companies ranked by revenue, at SGD 47.4B, ahead of Gilead Sciences (SGD 38B) and Biogen (SGD 12.8B). Figures as of 20 Nov 2026, 12:11 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 21
- First
- AmgenSGD 47.4B
- Median
- SGD 1.6B
- Combined market value
- SGD 1.07T
- Countries
- 5
- Not ranked
- 3no revenue on file
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | SGD 47.4B | SGD 306.1B | SGD 565.96 | 1.14% down | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | SGD 38B | SGD 266.4B | SGD 214.78 | 1.45% down | 31% up | ||
| 3 | BiogenBIIB · Health Care | SGD 12.8B | SGD 47.1B | SGD 318.73 | 1.70% down | 41% up | ||
| 4 | argenxARGX · Health Care | SGD 5.4B | SGD 76.4B | SGD 1,214.98 | 0.08% up | 3% up | ||
| 5 | BioNTechBNTX · Health Care | SGD 4.1B | SGD 26B | SGD 104.96 | 2.26% down | 15% down | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | SGD 3.7B | SGD 20.4B | SGD 201.96 | 3.85% down | 10% up | ||
| 7 | ExelixisEXEL · Health Care | SGD 3B | SGD 20.7B | SGD 84.90 | 3.60% down | 55% up | ||
| 8 | QiagenQGEN · Health Care | SGD 2.7B | SGD 13.2B | SGD 64.01 | 0.14% up | 6% up | ||
| 9 | ModernaMRNA · Health Care | SGD 2.5B | SGD 104B | SGD 257.08 | 1.29% up | 740% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | SGD 1.8B | SGD 13.7B | SGD 120.00 | 2.88% down | 32% up | ||
| 11 | Bio-TechneTECH · Health Care | SGD 1.6B | SGD 14.7B | SGD 93.76 | 0.07% down | 18% up | ||
| 12 | RepligenRGEN · Health Care | SGD 952.2M | SGD 14B | SGD 219.63 | 1.38% down | 5% up | ||
| 13 | Krystal BiotechKRYS · Health Care | SGD 501.9M | SGD 12.1B | SGD 407.32 | 0.15% up | 49% up | ||
| 14 | Twist BioscienceTWST · Health Care | SGD 485.7M | SGD 9.8B | SGD 143.96 | 4.07% down | 291% up | ||
| 15 | Adaptive BiotechnologiesADPT · Health Care | SGD 357.2M | SGD 5.9B | SGD 36.18 | 1.44% down | 51% up | ||
| 16 | ImmunityBioIBRX · Health Care | SGD 146.1M | SGD 9B | SGD 8.47 | 1.94% down | 216% up | ||
| 17 | Kymera TherapeuticsKYMR · Health Care | SGD 50.6M | SGD 13.1B | SGD 153.98 | 1.44% down | 81% up | ||
| 18 | CG OncologyCGON · Health Care | SGD 5.2M | SGD 9.4B | SGD 105.63 | 2.38% up | 93% up | ||
| 19 | CRISPR TherapeuticsCRSP · Health Care | SGD 4.5M | SGD 4.9B | SGD 50.21 | 3.14% down | 22% down | ||
| 20 | Revolution MedicinesRVMD · Health Care | SGD 0 | SGD 44.5B | SGD 205.62 | 0.24% down | 125% up | ||
| 21 | Scholar Rock HoldingSRRK · Health Care | SGD 0 | SGD 7.9B | SGD 64.96 | 4.94% up | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2897 SGD). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care biotech companies rank first by revenue?
Amgen (SGD 47.4B), Gilead Sciences (SGD 38B) and Biogen (SGD 12.8B) are the top three of the 21 health care biotech companies ranked by revenue as of 20 Nov 2026, 12:11 UTC.
How many health care biotech companies are in this ranking?
21 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these health care biotech companies worth together?
The 21 health care biotech companies ranked by revenue have a combined market value of SGD 1.07T as of 20 Nov 2026, 12:11 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care biotech companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.